Congress

Health Tech By Alicia Diaz

Federal watchdog raises concerns about increasing telehealth fraud during pandemic 

The Pharmalot View By Ed Silverman

By looking the other way, pharma money helped fuel a toxic political atmosphere in the U.S.

Exclusive By Rachel Cohrs

House Democrats slip drug pricing proposal into Covid-19 relief bill

Special Report By Rachel Cohrs

Hospitals’ Covid-19 heroics have them poised for power in the new Washington

Politics By Rachel Cohrs

Senate rules could pose hurdles for vaccine funds

Politics By Rachel Cohrs

After repeated delays, Trump’s HHS punts on oversight of a massive Covid-19 response fund for hospitals 

Politics By Nicholas Florko

Some Trump staffers face a slightly different revolving door

Politics By Lev Facher

Major health companies and trade groups suspend campaign contributions after Capitol riot

Politics By Nicholas Florko and Lev Facher

Democrats have their best shot yet at letting Medicare negotiate drug prices — but it’s still not a done deal

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: Biden’s plans for biopharma, a CES preview, & the next phase of the pandemic

Pharmalot By Ed Silverman

3 pharma trends to watch in 2021

Politics By Nicholas Florko

3 freshman lawmakers for health wonks to watch 

First Opinion By Stephen Northrup

Looking back and looking ahead: Vioxx, drug safety, and the legacy of Sen. Michael Enzi

Pharmalot By Ed Silverman

Sackler family members deny responsibility for the opioid crisis in a rare public appearance

First Opinion By Will Raderman, Elizabeth Pancotti, and Julia Raifman

Covid-19 is temporary. The health ramifications of failing to provide adequate economic relief may last decades

Politics By Lev Facher

PhRMA took in a record $527 million in 2019, new records show

Pharmalot By Ed Silverman

Sackler family members agree to testify at House hearing on Purdue’s role in opioid crisis

Politics By Lev Facher

Patrick Kennedy pitches himself for Biden ‘drug czar’

Politics By Nicholas Florko

Biden’s HHS pick, Becerra, has taken in more campaign cash from health groups than any other industry

Politics By Nicholas Florko

Burr, in line to lead Senate Republicans’ health strategy, has a long history of antagonizing the FDA

Pharmalot By Ed Silverman

House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies

Politics By Andrew Joseph, Lev Facher, Kate Sheridan, and Nicholas Florko

Shalala loses — and other 2020 election results that will have big implications for health and science

Politics By Lev Facher, Nicholas Florko, Andrew Joseph, and Kate Sheridan

Doctors in Congress, new e-cigarette taxes, stem cells, and abortion rights: Here’s what STAT is watching tonight

Politics By Lev Facher

In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’

Pharmalot By Ed Silverman

Lawmakers release trove of Purdue documents detailing Sackler family’s involvement in opioid sales